Skip to main content
John Laterra, MD, Neurology, Baltimore, MD, Kennedy Krieger Institute

JohnJosephLaterraMD

Neurology Baltimore, MD

Neurooncology

Professor of Neurology, Professor of Oncology, Johns Hopkins University School of Medicine; Co-Director, Brain Cancer Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Director, Division of Neuro-Oncology

Dr. Laterra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Laterra's full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemResidency, Neurology, 1984 - 1988
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1984

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • MD State Medical License
    MD State Medical License 1988 - 2024
  • PA State Medical License
    PA State Medical License 2020 - 2022
  • MI State Medical License
    MI State Medical License 1984 - 1988
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Effect of the mTOR Inhibitor Rapamycin on glucoCEST Signal in a Preclinical Model of Glioblastoma  
    John Laterra, MD, Magnetic Resonance in Medicine
  • CEST MRI of 3‐O‐Methyl‐D‐Glucose Uptake and Accumulation in Brain Tumors  
    John Laterra, MD, Magnetic Resonance in Medicine

Press Mentions

  • Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness Month
    Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness MonthMay 12th, 2022
  • Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness Month
    Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness MonthMay 12th, 2022
  • Brain Cancer's 'Immortality Switch' Turned off with CRISPR
    Brain Cancer's 'Immortality Switch' Turned off with CRISPRSeptember 10th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations